Texas
A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return.
The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.
Discussion (0)
No comments yet. Start the conversation!